4.3 Article

Preparation, quality control and biodistribution studies of [Ga-67]-DOTA-anti-CD20

Related references

Note: Only part of the references are listed.
Article Radiology, Nuclear Medicine & Medical Imaging

Tc-99m-rituximab radiolabelled by photo-activation: a new non-Hodgkin's lymphoma imaging agent

TG Stopar et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2006)

Article Radiology, Nuclear Medicine & Medical Imaging

Gallium-68-DOTA-albumin as a PET blood-pool marker: experimental evaluation in vivo

J Hoffend et al.

NUCLEAR MEDICINE AND BIOLOGY (2005)

Article Hematology

Imaging of central nervous system lymphomas with iodine-123 labeled rituximab

M Dietlein et al.

EUROPEAN JOURNAL OF HAEMATOLOGY (2005)

Article Radiology, Nuclear Medicine & Medical Imaging

177Lu-DOTA-lanreotide:: A novel tracer as a targeted agent for tumor therapy

S Banerjee et al.

NUCLEAR MEDICINE AND BIOLOGY (2004)

Article Biotechnology & Applied Microbiology

Imaging the pharmacodynamics of HER2 degradation in response to Hsp90 inhibitors

PM Smith-Jones et al.

NATURE BIOTECHNOLOGY (2004)

Article Chemistry, Inorganic & Nuclear

Design and synthesis of 225Ac radioimmunopharmaceuticals

MR McDevitt et al.

APPLIED RADIATION AND ISOTOPES (2002)

Article Chemistry, Inorganic & Nuclear

Evaluation of 90Y-DTPA and 90Y-DOTA for potential application in intra-vascular radionuclide therapy

U Pandey et al.

APPLIED RADIATION AND ISOTOPES (2002)

Article Radiology, Nuclear Medicine & Medical Imaging

Synthesis, characterization, and evaluation of a novel bifunctional chelating agent for the lead isotopes Pb-203 and Pb-212

LL Chappell et al.

NUCLEAR MEDICINE AND BIOLOGY (2000)